Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection
Summary:
Type:
Status:
Locations:
Bethesda, United States
Last Updated:
May 21, 2026
Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
Summary:
Type:
Status:
Interventions:
IV normal saline, IV immunoglobulin
Locations:
Bethesda, United States
Last Updated:
May 21, 2026
Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of COVID-19 (PASC)
Summary:
Type:
Status:
Interventions:
A.1 - [¹⁸F]F-AraG PET/CT (90-min dynamic + 4-h static), A.2 - [¹⁸F]F-AraG PET/CT (60-min dynamic only), B.1 - [¹⁸F]F-AraG PET/CT (90-min dynamic + 4-h static), B.2 - [¹⁸F]F-AraG PET/CT (60-min dynamic only)
Locations:
Sacramento, United States; San Francisco, United States;
Last Updated:
May 19, 2026
Collection of SARS CoV-2 (COVID-19) Virus Secretions and Serum for Countermeasure Development
Summary:
Type:
Status:
Locations:
New Orleans, United States; New Orleans, United States;
Last Updated:
May 18, 2026
Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease
Summary:
Type:
Status:
Interventions:
Kisspeptin 112-121
Locations:
Boston, United States
Last Updated:
May 16, 2026
Low Dose Sirolimus in People With Post-Acute Sequelae of COVID-19 (PASC) Long COVID-19
Summary:
Type:
Status:
Interventions:
Low-dose sirolimus, Placebo
Locations:
New York, United States
Last Updated:
May 14, 2026
Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection Associated Chronic Conditions
Summary:
Type:
Status:
Locations:
Palo Alto, United States; Rochester, United States; and 2 more
Last Updated:
May 14, 2026
A Study to Examine Anktiva for the Treatment of COVID-19.
Summary:
Type:
Status:
Interventions:
Anktiva
Locations:
El Segundo, United States
Last Updated:
May 8, 2026
A Study to Assess Anktiva in Patients With Long Covid-19.
Summary:
Type:
Status:
Interventions:
N-803 (IL-15 Superagonist)
Locations:
San Francisco, United States
Last Updated:
May 8, 2026
DMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine Injury
Summary:
Type:
Status:
Interventions:
DMSO-based otic solution with betahistine, dexamethasone, and lidocaine, DMSO-based transdermal cream with levocarnitine and N-acetylcysteine
Locations:
Ithaca, United States
Last Updated:
May 8, 2026